WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
69.58
-0.82 (-1.16%)
Jul 9, 2025, 2:45 PM CST
83.01%
Market Cap 199.50B
Revenue (ttm) 39.59B
Net Income (ttm) 11.18B
Shares Out 2.85B
EPS (ttm) 3.24
PE Ratio 18.44
Forward PE 16.34
Dividend 0.98 (1.39%)
Ex-Dividend Date May 21, 2025
Volume 21,639,665
Average Volume 29,981,753
Open 69.39
Previous Close 70.40
Day's Range 68.90 - 70.98
52-Week Range 36.36 - 71.65
Beta 0.76
RSI 63.98
Earnings Date Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.